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heterogeneous Vascular Bed 
responses to Pulmonary Titanium 
Dioxide nanoparticle exposure
Alaeddin B. Abukabda1, Phoebe A. Stapleton2, Carroll R. McBride1, Jinghai Yi1 and 
Timothy R. Nurkiewicz1*
1 Department of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV, USA, 
2 Department of Pharmacology and Toxicology, Rutgers University, Piscataway, NJ, USA
A growing body of research links engineered nanomaterial (ENM) exposure to adverse 
cardiovascular endpoints. The purpose of this study was to evaluate the impact of ENM 
exposure on vascular reactivity in discrete segments so that we may determine the most 
sensitive levels of the vasculature where these negative cardiovascular effects are mani-
fest. We hypothesized that acute nano-TiO2 exposure differentially affects reactivity with 
a more robust impairment in the microcirculation. Sprague-Dawley rats (8–10 weeks) 
were exposed to nano-TiO2 via intratracheal instillation (20, 100, or 200 µg suspended 
per 250 µL of vehicle) 24 h prior to vascular assessments. A serial assessment across 
distinct compartments of the vascular tree was then conducted. Wire myography was 
used to evaluate macrovascular active tension generation specifically in the thoracic 
aorta, the femoral artery, and third-order mesenteric arterioles. Pressure myography 
was used to determine vascular reactivity in fourth- and fifth-order mesenteric arterioles. 
Vessels were treated with phenylephrine, acetylcholine (ACh), and sodium nitroprusside. 
Nano-TiO2 exposure decreased endothelium-dependent relaxation in the thoracic aorta 
and femoral arteries assessed via ACh by 53.96 ± 11.6 and 25.08 ± 6.36%, respectively. 
Relaxation of third-order mesenteric arterioles was impaired by 100 and 20 µg nano-
TiO2 exposures with mean reductions of 50.12 ± 8.7 and 68.28 ± 8.7%. Cholinergic 
reactivity of fourth- and fifth-order mesenteric arterioles was negatively affected by 
nano-TiO2 with diminished dilations of 82.86 ± 12.6% after exposure to 200 µg nano-
TiO2, 42.6 ± 12.6% after 100 µg nano-TiO2, and 49.4 ± 12.6% after 20 µg nano-TiO2. 
Endothelium-independent relaxation was impaired in the thoracic aorta by 34.05 ± 25% 
induced by exposure to 200 µg nano-TiO2 and a reduction in response of 49.31 ± 25% 
caused by 100 µg nano-TiO2. Femoral artery response was reduced by 18 ± 5%, while 
third-order mesenteric arterioles were negatively affected by 20  µg nano-TiO2 with a 
mean decrease in response of 38.37 ± 10%. This is the first study to directly compare 
the differential effect of ENM exposure on discrete anatomical segments of the vascular 
tree. Pulmonary ENM exposure produced macrovascular and microvascular dysfunction 
resulting in impaired responses to endothelium-dependent, endothelium-independent, 
and adrenergic agonists with a more robust dysfunction at the microvascular level. These 
results provide additional evidence of an endothelium-dependent and endothelium- 
independent impairment in vascular reactivity.
Keywords: engineered nanomaterials, titanium dioxide, cardiovascular system, microcirculation, endothelium
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inTrODUcTiOn
Engineered nanomaterials (ENMs) are most commonly defined 
as a homogeneous mixture of anthropogenic materials possessing 
at least one dimension less than or equal to 100 nm (1) and have 
historically been used in inhalation toxicology research as sur-
rogates for environmental air pollution studies to model ultrafine 
particulate matter exposures (2, 3). The continued development 
of novel ENM with diverse physicochemical properties repre-
sents a growing economic sector. Presently, the nanotechnology 
industry is one of the fastest growing markets with an estimated 
projected worth of $75.8 billion by 2020 (4). This increased 
prevalence of ENM not only continues concerns over their safety 
and the potential adverse health outcomes that may occur as a 
result of prolonged, unmitigated exposure but also warrants more 
thorough toxicological assessments of their potential deleterious 
systemic effects.
Titanium dioxide (nano-TiO2) is among the most widely used 
nanomaterials, and its optical properties allow it to be used in 
consumer products such as topical sunscreens and cosmetics, 
as well as industrial components including paints (5). It is used 
commonly as a photocatalyst, catalyst carrier, heat stabilizer, and 
food additive (6). Nano-TiO2 may also be used as a drug carrier 
in nanomedicine (7).
Pulmonary nano-TiO2 exposure has been associated with 
systemic inflammation in vivo (8–10), with dose dependent overt 
inflammation characterized by a marked increase in proinflam-
matory mediators and lung toxicity (10, 11).
The circulatory system can be grossly divided into two major 
components based on structure and location: the macrocircula-
tion and the microcirculation. The macrocirculation refers to the 
conduit arteries and veins, which connect the heart with the sys-
temic organs and also function as pressure and blood reservoirs, 
respectively. The microcirculation is a broad term encompassing 
all the vascular tissue within a specific organ, including arterioles, 
the capillary network, and venules (12). Its fundamental func-
tion is the maintenance of an ideal internal environment for the 
controlled exchange of nutrients and metabolic waste with the 
adjacent tissues. For this study, conduit arteries and arterioles 
were chosen because they are major hemodynamic regulators and 
key players in the maintenance of blood pressure, flow distribu-
tion, and tissue perfusion (13, 14).
The endothelium is a regulator of vascular homeostasis and 
is extremely sensitive to changes in blood composition and 
hemodynamics (15). Consisting of a monolayer of cells that func-
tions as a physical barrier for the exchange of materials between 
blood and tissues (16), it is also responsible for the secretion of a 
variety of molecules, including prostacyclins (17), clotting factors 
(18), and ectonucleotidases (19) that are important for the regula-
tion of blood coagulation and platelet function. Endothelial cells 
also coordinate the recruitment of immune cells to sites of injury 
or infection via both the production and release of cytokines 
(20) and the expression of specific cell adhesion molecules on 
their apical surface that mediate leukocyte attachment and 
extrava sation (21–24). While common to all vascular segments, 
endothelial cells show significant morphological and functional 
het ero geneity throughout the vasculature, between different organs, 
and between neighboring endothelial cells of the same organ 
and blood vessel type (25). These phenotypic differences may 
account for the differential and vascular bed-specific responses 
of endothelial cells to specific toxicants.
We have previously established that nano-TiO2 exposure 
is associated with systemic vascular dysfunction (26–28). 
However, the relative sensitivity to ENM of each vascular seg-
ment is not known. Therefore, the aim of this study is to assess 
the effects of three occupationally relevant nano-TiO2 concen-
trations on both the macrocirculation and the microcirculation 
from a functional perspective via wire and pressure myography. 
One hundred micrograms of nano-TiO2 were selected based on 
previous work conducted by our group (2). In addition, 200 
and 20 µg were chosen for this study to identify the maximum 
and minimum observed dose responses. The most sensitive 
vascular level to nano-TiO2 exposure was subsequently deter-
mined. On the basis of our previous results, we hypothesize 
that nano-TiO2 exposure impairs endothelium-dependent 
responsiveness and that this effect is more pronounced in the 
microcirculation.
MaTerials anD MeThODs
nanomaterial characterization
Nano-TiO2 P25 powder, obtained from Evonik (Aeroxide TiO2, 
Parsippany, NJ, USA), has previously been shown to be a mixture 
composed primarily of anatase (80%) and rutile (20%) TiO2, with 
a primary particle size of 21 nm and a surface area of 48.08 m2 g−1 
(2, 29, 30).
experimental animals and exposure
Male (8–10  weeks) Sprague–Dawley rats were purchased from 
Hilltop Laboratories (Scottdale, PA, USA) and housed at WVU 
with 12:12 h light–dark cycle and regulated temperature. Rats were 
allowed ad libitum access to food and water. All procedures were 
approved by the Institutional Animal Care and Use Committee 
of West Virginia University and abide by the standards set forth 
in the “Guide for Care and Use of Laboratory Animals” of the 
National Research Council of the National Academies.
Bolus doses of nano-TiO2 (20, 100, and 200  µg) were sus-
pended in 250  µL of vehicle (normosol and 5% fetal bovine 
serum) for intratracheal instillation (IT) 24  h prior to experi-
mentation. Nano-TiO2 suspensions were sonicated over ice for 
1 min to ensure increased dispersion. Sprague-Dawley rats were 
anesthetized using 5% isoflurane and placed on a mounting stand 
for IT with 200 µL of vehicle (negative control) or the nano-TiO2 
suspensions.
Mean arterial Pressure (MaP) acquisition
Rats were anesthetized with isoflurane gas (5% induction, 
3–3.5% maintenance) and placed on a heating pad to maintain 
a 37°C rectal temperature. The trachea was intubated to ensure 
an open airway, and the right carotid artery was cannulated 
to acquire MAP. PowerLab830 (AD Instruments) was used to 
record MAP.
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Wire Myography arterial ring Preparation
The thoracic aorta, common femoral artery, and third-order 
mesenteric arterioles were dissected and immediately placed in 
ice cold Ringer’s solution. Two- to three-mm segments were cut 
and mounted in each wire myograph chamber (AD Instruments—
DMT 620  M) containing 5  mL of physiological salt solution 
(PSS; 119 mM NaCl, 4.7 mM KCl, 1.18 mM KH2PO4, 1.17 mM 
MgSO4, 2.5 mM CaCl2, 25 mM NaHCO3, 0.027 mM EDTA, and 
5.5 mM glucose) at pH 7.4 and bubbled with 95% O2/5% CO2 
at 37°C. After 30  min of equilibration, maximum contractile 
response was determined by using high-potassium PSS (K + PSS; 
123.7  mM KCl, 1.18  mM KH2PO4, 1.17  mM MgSO4, 2.5  mM 
CaCl2, 25 mM NaHCO3, 0.027 mM EDTA, and 5.5 mM glucose). 
Vessels were then washed twice with PSS and allowed to relax 
until initial tension was reached. Contractile responses were 
determined via cumulative additions of 50 µL of phenylephrine 
(PE; 1 × 10−9 to 1 × 10−4 M). Relaxation responses were evaluated 
via cumulative addition of 50 µL acetylcholine (ACh) or sodium 
nitroprusside (SNP) (1 × 10−9 to 1 × 10−4 M).
statistics
Point-to-point differences in the dose–response curves were 
evaluated using two-way repeated measures analysis of variance 
(ANOVA) with a Tukey’s post  hoc analysis when significance 
was found. The slopes of the dose–response curves were deter-
mined through non-linear regression. The animal characteristics, 
vessel characteristics, and dose–response curve slopes were ana-
lyzed using a one-way ANOVA with a Tukey’s post hoc analysis 
when significance was found. All statistical analysis was comple-
ted with GraphPad Prism 5 (San Diego, CA, USA) and Sigma 
Plot 11.0 (San Jose, CA, USA). Significance was set at P < 0.05, 
n is the number of arterioles, and N is the number of animals.
Wire Myography calculations
Maximum tension was defined as the tension developed by the 
vessels with K + PSS. Tension with agonists (ACh, SNP, or PE) 
was recorded, and the percentage of maximum tension genera-
tion was calculated using the following formula:
 
Percentage maximum tension (%)
Tension with agonists (mN)
M
=
aximum tension (mN)
%.




×100
 
The response of the different arterial branching orders was 
quantitatively assessed and compared by using the slope of the 
individual dose–response curves as previously reported (31).
Pressure Myography arteriolar 
Preparation
The mesentery was excised and placed in a dissecting dish with 
PSS maintained at 4°C. Fourth- and fifth-order mesenteric arte-
rioles were isolated, transferred to a vessel chamber, cannulated 
between two glass pipettes (outer diameter 60 µm), and secured 
by means of silk sutures in the vessel chamber (Living Systems 
Instrumentation, Burlington, VT, USA). The chamber was super-
fused with fresh oxygenated (5% CO2/21% O2) PSS and warmed 
to 37°C. Arterioles were pressurized to 60 mmHg using a servo 
control system and extended to their in situ length. Internal and 
external arteriolar diameters were measured using video calipers 
(Colorado Video, Boulder, CO, USA).
arteriolar reactivity
Arterioles were equilibrated for 1  h prior to experimentation. 
Arterioles with <20% spontaneous tone were not analyzed. 
Contractile responses were determined via cumulative additions 
of 50 µL of PE (1 × 10−9 to 1 × 10−4 M). Relaxation responses 
were evaluated via cumulative addition of 50 µL ACh or sodium 
nitroprusside (SNP) (1 × 10−9 to 1 × 10−4 M). The steady-state 
diameter of the vessel was recorded for at least 2 min after each 
dose. After each dose curve was completed, the vessel chamber 
was washed to remove excess chemicals by carefully removing 
the superfusate and replacing it with fresh warmed oxygenated 
PSS. After all experimental treatments were completed, the PSS 
was replaced with Ca2+-free PSS until maximum passive diameter 
was established.
Pressure Myography calculations
All measurements were conducted during steady-state condi-
tions, with steady state being defined as the interval during which 
blood vessels maintained a stable tone for 1 min or more. Vessels 
were washed twice with PSS between individual dose–response 
treatments and allowed approximately 10 min for equilibration 
or until original tone was developed. Data are expressed as 
means ± SE. Spontaneous tone was calculated by the following 
equation:
 
Spontaneous tone ( ) m i
i
% ,( )= −








×
D D
D
100
 
where Dm is the maximal diameter and Di is the initial steady-state 
diameter recorded prior to the experiment. Active responses to 
pressure were normalized to the maximal diameter using the 
following formula:
 Normalized diameter ss m= D D/ , 
where Dss is the steady-state diameter recorded during each pres-
sure change. The experimental responses to ACh and SNP are 
expressed using the following equation:
 
Diameter (percent maximal diameter) ss con
m con
=
−
−


( )
( )
D D
D D




×100,
 
where DCon is the control diameter recorded prior to the dose 
curve and DSS is the steady-state diameter at each dose of the 
curve. The experimental response to PE is expressed using the 
following equation:
 
Diameter (percent maximal diameter) con ss
con
=
−



( )
( )
D D
D 


×100.
 
Wall thickness was calculated from the measurement of both 
inner (ID) and outer (OD) steady-state arteriolar diameters at the 
end of the Ca2+-free wash using the following equation:
 WT OD ID= −( ) / .2  
TaBle 2 | arteriolar characteristics.
n inner diameter 
(μm)
Outer diameter 
(μm)
Tone  
(%)
Passive diameter 
inner (μm)
Passive diameter 
outer (μm)
Wall thickness 
(μm)
Wall-to-lumen 
ratio
Wall tension 
(n m−1)
Sham control 11 115.4 ± 10 139.4 ± 17 31.2 ± 7 183.6 ± 11 152 ± 8 16 ± 3 0.104 ± 0.03 0.61 ± 0.2
Nano-TiO2 200 µg 10 134.3 ± 11* 146.2 ± 15 22.4 ± 4* 187 ± 20 153.7 ± 19 17 ± 1 0.108 ± 0.02 0.62 ± 0.1
Nano-TiO2 100 µg 9 128 ± 19* 144.6 ± 24 23.5 ± 1* 182.5 ± 11 148.7 ± 10 17 ± 3 0.11 ± 0.02 0.6 ± 0.3
Nano-TiO2 20 µg 10 110.7 ± 12 145.9 ± 12 20.3 ± 3 180.4 ± 16 152.6 ± 14 14 ± 2 0.09 ± 0.03 0.61 ± 0.1
Fourth- and fifth-order mesenteric arterioles characteristics are shown. Values are shown as mean ± SEM. Statistics were analyzed with two-way analysis of variance (P ≤ 0.05).
n, number of vessels.
*P ≤ 0.05 vs. sham control.
TaBle 1 | animal characteristics.
Treatment number of rats (N) age (weeks) Body weight (g) Mean arterial pressure (mmhg) heart rate (bpm)
Sham control 16 8.5 ± 0.2 288 ± 18 90 ± 4 336 ± 18
Nano-TiO2 200 µg 17 9.3 ± 0.4 295 ± 18 94 ± 4 330 ± 8
Nano-TiO2 100 µg 16 9.5 ± 0.1 319 ± 10 82 ± 3 323 ± 10
Nano-TiO2 20 µg 12 9.4 ± 1.5 322 ± 19 87 ± 3 311 ± 16
Physical characteristics of control and exposed rats are listed. Values are shown as mean ± SEM. Statistics were analyzed with two-way analysis of variance (P ≤ 0.05).
N, number of animals.
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Wall-to-lumen ratio was calculated using the following 
equation:
 WLR WT ID.= /  
resUlTs
animal and Vessel characteristics
No significant changes were observed in age, MAP, heart rate, 
and body weight between control and exposure groups (Table 1). 
Active inner diameter of fourth and fifth order mesenteric arteri-
oles exposed to 200 µg of nano-TiO2 (134.3 ± 11 µm) and 100 µg 
of nano-TiO2 (128.3 ± 19 µm) were significantly different from 
control values (115.4 ± 10 µm), while passive diameter remained 
unchanged. This increase in diameter was associated with a 
decreased initial vascular tone (Table 2).
endothelium-Dependent reactivity
Two hundred micrograms of nano-TiO2 significantly impaired 
endothelium-dependent relaxation of thoracic aorta (Figure 1A) 
with a mean decrease in response to ACh of 53.96 ±  11.6%. 
No significant effects were seen at 100 and 20 µg of nano-TiO2 
(Figure 1A).
Femoral arteries from exposed animals showed a reduced 
cholinergic response solely at the lowest exposure concentration 
(20 µg nano-TiO2/250 μL of vehicle) of 25.08 ± 6.36% (Figure 1B). 
Further, 100 and 20 µg nano-TiO2 exposure resulted in a mean 
reduction in relaxation of third-order mesenteric arterioles of 
50.12 ± 8.7 and 68.28 ± 8.7%, respectively (Figure 1C). Finally, 
cholinergic reactivity of fourth- and fifth-order mesenteric 
arterioles was negatively affected by nano-TiO2 with diminished 
dilations of 82.86 ± 12.6% after exposure to 200 µg nano-TiO2, 
42.6 ± 12.6% after 100 µg nano-TiO2, and 49.4 ± 12.6% after 20 µg 
nano-TiO2 (Figure 1D).
To consider the fullest scope of the biological response across 
the discrete entities of the vasculature, the slope of the individual 
dose–response curves was utilized as a means of numerically 
quantifying vascular reactivity (Figure 2) as previously shown 
(7, 31). Exposure to 200 µg of nano-TiO2 decreased sensitivity 
to ACh from 16.29 ± 1.2 to 3.99 ± 1.1 M−1. Similarly, vascular 
reactivity of femoral arteries was diminished from the control 
value of 12.43 ± 1.7 to 7.77 ± 3.6 M−1 and 7.44 ± 3.1 M−1 with 
200 and 100 µg nano-TiO2, respectively. Third-order mesenteric 
arterioles showed a dose-dependent reduction in ACh sensitivity 
from control levels (16.76 ± 2.9 M−1) with 100 µg nano-TiO2 
having the greatest deleterious effect (2.98 ±  1.3  M−1), while 
200 and 20 µg nano-TiO2 reduced responsiveness to 6.93 ± 3.2 
and 3.46  ±  0.99  M−1, respectively. Fourth- and fifth-order 
mesenteric arterioles showed the greatest decrease in vascular 
reactivity from controls (14.73 ±  1.5  M−1) particularly with 
200  µg nano-TiO2 (−11.46 ±  5.1  M−1) and 20  µg nano-TiO2 
(−1.55 ± 0.8 M−1), while vessels exposed to 100 µg nano-TiO2 
showed slight ACh sensi tivity (1.15 ±  0.4 M−1). These results 
provide additional evidence of an endothelium-dependent 
effect associated with nanomaterial exposure. The heterogene-
ity in impairment across the vasculature indicates the microcir-
culation as the prime site where these effects are most markedly 
manifest.
α-adrenergic sensitivity
In contrast to endothelium-dependent relaxation, no point- 
to-point differences were seen in α-adrenergic responses across 
all levels of the vasculature between nano-TiO2-exposed and 
control groups (Figures 3A–D). However, slope analysis, wherein 
the entire continuum of the vascular PE responses is assessed, 
revealed significant differences in vascular sensitivity induced 
by nano-TiO2 (Figure  4). Aortic PE sensitivity was increased 
by exposure to 100 µg nano-TiO2 (11.2 ± 1.3 M−1) with respect 
FigUre 1 | endothelium-dependent dilation is impaired by intratracheal instillation of nano-TiO2. acetylcholine (ACh)-induced vascular reactivity in  
(a) aorta, (B) femoral artery, (c) third-order mesenteric arterioles, and (D) fourth- and fifth-order mesenteric arterioles (n = 10–11). Statistics were analyzed  
with two-way analysis of variance (ANOVA) (P ≤ 0.05). *Sham control group vs. nano-TiO2-exposed groups.
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to control values (14.35 ±  0.56  M−1). Significantly augmented 
adrenergic responses were seen in the femoral artery with 
100 (9.35 ±  3.2  M−1) and 20  µg nano-TiO2 (9.39 ±  1.7  M−1). 
Also, 200  µg nano-TiO2 (6.03 ±  2  M−1) and 20  µg nano-TiO2 
(6.36 ±  1.4  M−1) caused increased vascular reactivity of third 
order mesenteric arterioles relative to controls (1.95 ± 2.7 M−1). 
Lastly, fourth and fifth mesenteric arterioles from exposed ani-
mals showed a clear proconstrictive effect particularly at 200 µg 
nano-TiO2 (19.9 ±  2  M−1) and 20  µg (24.07 ±  1.7  M−1), with 
100 µg (19.9 ±  2 M−1) leading to responses similar to controls 
(16.33 ± 0.84 M−1) (Figure 4). This effect is consistent with previ-
ous work (26, 32) and confirms a potential effect on sympathetic 
tone, associated with ENM exposure.
endothelium-independent reactivity
Endothelium-independent relaxation assessed via the 
 spontaneous NO donor SNP was impaired in the thoracic aorta 
with a mean decrease in response of 34.05 ± 25% induced by 
exposure to 200  µg nano-TiO2 and a reduction in response 
of 49.31  ±  25% caused by 100  µg nano-TiO2 (Figure  5A). 
Similarly, the response of the femoral artery to SNP was 
reduced by 18  ±  5% (Figure  5B). Third-order mesenteric 
arterioles were negatively affected by 20  µg nano-TiO2 with 
a mean decrease in response of 38.37  ±  10% (Figure  5C). 
It is interesting to note that slope analysis demonstrated a 
decrease in SNP sensitivity only in thoracic aorta at 200  µg 
(21.28 ±  2.03  M−1) and 100  µg (18.91 ±  2.1  M−1) nano-TiO2 
compared to control (26.46 ± 3.08 M−1) (Figure 6). Similarly, 
fourth- and fifth-order mesenteric arteriolar sensitivity 
to SNP was significantly reduced from (18.13  ±  1.6  M−1) 
to (15.99 ±  1.79  M−1) by exposure to 20  µg nano-TiO2. This 
is consistent with previous findings where impairments in 
endothelium-independent dilation in the microcirculation are 
not noted (33–35).
FigUre 3 | α-adrenergic response to phenylephrine (Pe) is not affected by nano-TiO2. PE response in (a) aorta, (B) femoral artery, (c) third order 
mesenteric arterioles, and (D) fourth and fifth mesenteric arterioles (n = 10–11). Statistics were analyzed with two-way analysis of variance (ANOVA) (P ≤ 0.05). 
FigUre 2 | acetylcholine (ach) sensitivity and vascular reactivity are 
decreased by nano-TiO2 exposure. Bar graphs showing the individual 
slope values for sham control and exposed vessels (n = 9–11). Statistics 
were analyzed with two-way analysis of variance (P ≤ 0.05). *Sham control 
group vs. nano-TiO2-exposed groups.
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DiscUssiOn
This is the first study to directly compare the differential effect of 
ENM exposure on discrete anatomical segments of the vascular 
tree. Pulmonary ENM exposure produced macrovascular and 
microvascular dysfunction resulting in impaired responses to 
endothelium-dependent, endothelium-independent, and adren-
ergic agonists. The major finding of this article is that acute nano-
TiO2 pulmonary exposure results in a more robust dysfunction at 
the microvascular level, and this is not simply because arterioles 
possess greater reactivity than arteries.
The microcirculation is critical in the regulation of the 
vascular internal environment for the controlled exchange of 
nutrients and metabolic waste with the adjacent tissues. Spe-
cifically, arterioles are major hemodynamic regulators and 
key players in the maintenance of blood pressure and flow 
distribution (13, 14). Disruptions in microvascular function 
are commonly associated with health consequences such as 
FigUre 4 | Phenylephrine (Pe) sensitivity are augmented by 
nano-TiO2 exposure. Bar graphs showing the individual slope values for 
sham control and exposed vessels (n = 10–11). Statistics were analyzed with 
two-way analysis of variance (ANOVA) (P ≤ 0.05). *Sham control group vs. 
nano-TiO2-exposed groups.
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FigUre 5 | endothelium-independent dilation and vascular smooth muscle function is not impaired by nano-TiO2 exposure. Sodium nitroprusside 
(SNP) response in (a) aorta, (B) femoral artery, (c) third-order mesenteric arterioles, and (D) fourth- and fifth-order mesenteric arterioles (n = 10–11). Statistics were 
analyzed with two-way analysis of variance (ANOVA) (P ≤ 0.05). * Sham control group vs. nano-TiO2-exposed groups.
hypertension and diabetes, and this is largely due to endothelial 
dysfunction (36).
The pronounced effect of ENM exposure on the microcircula-
tion may be due to the propensity of nanoparticles to accumulate 
preferentially in this vascular compartment. Considerable 
evidence exists suggesting that after the initial exposure, nanoma-
terials tend to translocate and accumulate systemically (37, 38). 
Due to the existing hydrodynamic influences present within the 
microcirculation, it has been hypothesized that ENM deposition 
would likely be highest in the arterioles (39). Within arterioles, 
ENM may directly impair vascular function via generation of 
free radicals, decreasing NO bioavailability, NO synthase uncou-
pling, or by altering sympathetic tone.
Cholinergic activity was assessed using ACh. In normal 
conditions, ACh activates endothelial NO synthase (eNOS) 
by stimulating the release of intracellular calcium. l-Arginine 
is converted to l-citrulline by eNOS with the production of 
NO. eNOS requires a number of cofactors, including NADPH, 
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FigUre 6 | sodium nitroprusside (snP)-induced vascular reactivity is 
unaffected by nano-TiO2 exposure. Bar graphs showing the individual 
slope values for sham control and exposed vessels (n = 10–11). Statistics 
were analyzed with two-way analysis of variance (ANOVA) (P ≤ 0.05). *Sham 
control group vs. nano-TiO2-exposed groups.
FAD, calcium, calmodulin, and BH4. NO subsequently diffuses 
into vascular smooth muscle cells and stimulates guanylate 
cyclase, ultimately resulting in cGMP production and vasodi-
lation. In this study, reduced reactivity was seen in the thoracic 
aorta, femoral artery, third-order mesenteric arterioles and 
fourth-/fifth-order mesenteric arterioles. These effects are 
consistent with previous results obtained by our group and 
others (32, 40, 41). It is interesting to note, however, that 
exposure to 200 µg nano-TiO2 resulted in a complete reversal of 
the vasodilatory response by fourth-/fifth-order mesenteric 
arterioles, potentially indicating severe irreparable damage to 
the endothelial layer.
The endothelium is a major regulatory component common 
to all levels of the vasculature and plays a critical role in the 
control of vascular tone, the inflammatory response, main-
tenance and regulation of blood fluidity, permeability, and 
angiogenesis (42). Due to the significant role played in vascular 
homeostasis, it is becoming increasingly recognized that the 
endothelium is involved in most disease conditions, either as 
a primary determinant of pathophysiology or as a result of 
collateral damage (43).
No point-to-point impairments were seen in the response 
to the α-adrenergic agonist PE. However, when considering 
the whole continuum of the vascular responses to this agonist, 
a prevalent increase in sensitivity, particularly at the microvas-
cular level, was observed (Figure  4), consistent with previous 
work (26, 32).
Finally, endothelium-independent dysfunction was observed 
primarily in the macrocirculation, including the thoracic aorta, 
femoral artery, and third-order mesenteric arterioles (Figures 5 
and 6). This differential effect on vascular smooth muscle 
response in the macrocirculation may be caused by the 
turbulent flow patterns characteristic of this segment, which 
contribute to an increased likelihood of deposition and 
impaction of ENM agglomerates particularly at large artery 
bifurcations (39).
Dysfunction in vascular smooth muscle following particulate 
matter exposure was first reported in pulmonary arteries by 
Courtois et al. (44). Previous work attributed this effect to a pro-
inflammatory response triggered by particulate matter exposure, 
while other studies linked vascular dysfunction to an increase in 
oxidative stress (45).
Historically, the adverse systemic effects associated with 
pulmonary ENM exposure have been ascribed to a host 
inflammatory response, direct particle–tissue interactions, 
and/or autonomic dysregulation (3). The observed macrovas-
cular and microvascular dysfunction could be associated with 
impaired NO production, a decrease in NO bioavailability 
caused by the generation of reactive oxygen species within 
the vascular wall, a shift in arachidonic acid metabolites, or 
vascular smooth muscle impairment or a combination of these 
mechanisms. It is outside the scope of this study to determine 
the mechanisms underlying the vascular endpoints herein 
reported, and future experiments are necessary to elucidate 
these mechanisms.
While the results of this study provide further indications of 
the microvascular effects associated with ENM, it is admittedly 
not without its limitations. Wire myography assesses the tension 
generated by vascular rings under isometric tension and therefore 
caution should be taken when interpreting the results obtained. 
This is particularly so for conduit arteries, in which changes in 
wall tension do not explicitly translate into vasomotion. Further, 
the use of in vitro techniques to evaluate vascular reactivity elimi-
nates neurogenic and hormonal influences, which also play an 
important role in the mechanism of ENM cardiovascular toxicity. 
Therefore, future experiments utilizing ex vivo preparations (such 
as intravital microscopy) may be more appropriate to obtain a 
more thorough assessment.
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